A carregar...
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond
Chimeric antigen receptors (CARs) are versatile synthetic receptors that provide T cells with engineered specificity. Clinical success in treating B-cell malignancies has demonstrated the therapeutic potential of CAR-T cells against cancer, and efforts are underway to expand the use of engineered T...
Na minha lista:
| Publicado no: | Trends Mol Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5423782/ https://ncbi.nlm.nih.gov/pubmed/28416139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmed.2017.03.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|